Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease.

[1]  I. D. de Boer,et al.  Urinary Creatinine Excretion Rate and Mortality in Persons With Coronary Artery Disease: The Heart and Soul Study , 2010, Circulation.

[2]  K. Shimada,et al.  Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)-a randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events. , 2010, American heart journal.

[3]  C. Meisinger,et al.  Myocardial infarction and incidence of type 2 diabetes mellitus. Is admission blood glucose an independent predictor for future type 2 diabetes mellitus? , 2010, American heart journal.

[4]  J. Woodside,et al.  Adoption and maintenance of a Mediterranean diet in patients with coronary heart disease from a Northern European population: a pilot randomised trial of different methods of delivering Mediterranean diet advice. , 2010, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.

[5]  A. Oulhaj,et al.  Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy , 2009, European heart journal.

[6]  A. Zwinderman,et al.  Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study , 2009, Heart.

[7]  Jeroen J. Bax,et al.  Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood , 2009, Heart.

[8]  A. Khera,et al.  Evaluation of coronary artery calcium screening strategies focused on risk categories: the Dallas Heart Study. , 2009, American heart journal.

[9]  D. Knol,et al.  Variable selection under multiple imputation using the bootstrap in a prognostic study , 2007, BMC medical research methodology.

[10]  R. Califf,et al.  Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease , 2006, Circulation.

[11]  M. Walsh,et al.  Impact of amiodarone versus implantable cardioverter defibrillator therapy on the mode of death in congestive heart failure patients in the SCDHeFT trial , 2005 .

[12]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[13]  G. Sanders,et al.  Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. , 2002, American heart journal.

[14]  J. McSweeney.  Women’s Prodromal Symptoms of Myocardial Infarction , 2001 .

[15]  C B Granger,et al.  Risk stratification and therapeutic decision making in acute coronary syndromes. , 2000, JAMA.

[16]  F. Harrell,et al.  Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. , 1994, Circulation.

[17]  M A Hlatky,et al.  Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. , 1988, Journal of the American College of Cardiology.

[18]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.